Skip to main content

Select Drug Profiles

Practice Management
Hospital and Health Plan Partnerships: The Affordable Care Act’s Impact on Promoting Health and Wellness
Michelle Vu, PharmD candidate, Annesha White, PharmD, PhD, Virginia P. Kelley, MBA, Jennifer Kuca Hopper, MS, Cathy Liu, PharmD candidate
Stakeholder Perspective
Measurable Clarity in Healthcare Is Needed So Those Who Use the System Could Achieve a State of Well-Being
by F. Randy Vogenberg, PhD, FASHP
Read More
Practice Management
Oncologist Support for Consolidated Payments for Cancer Care Management in the United States
Siva Narayanan, MSc, Emily Hautamaki, MPH
Stakeholder Perspective
Implementing Payment Reform in Oncology: Benefits and Challenges
by Byron C. Scott, MD, MBA
Read More
FDA Approvals, In the News
Nuplazid First Drug Approved for Hallucinations and Delusions Associated with Parkinson’s Disease
Read More
FDA Approvals, In the News
Zynbrita a New Treatment Available for Relapsing Multiple Sclerosis
Read More
Perspectives
Navigating the “Hassle Map”
David B. Nash, MD, MBA
Read More
Practice Management
Patient-Reported Outcomes in Oncology Drug Labeling in the United States: A Framework for Navigating Early Challenges
Alan L. Shields, PhD, Yanni Hao, PhD, Meaghan Krohe, PhD, Andrew Yaworsky, Iyar Mazar, MA, Catherine Foley, MPH, MA, Faisal Mehmed, MD, Denise Globe, PhD
Stakeholder Perspective
Patient-Reported Outcomes in Oncology: Challenges and Opportunities for All Stakeholders
by Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Practice Management
Economic Burden of Toxicities Associated with Treating Metastatic Melanoma in the United States
S. Pinar Bilir, MS, Qiufei Ma, PhD, Zhongyun Zhao, PhD, Elizabeth Wehler, MPH, Julie Munakata, MS, Beth Barber, PhD
Stakeholder Perspective
Reducing Adverse Events and Healthcare Resource Waste by Careful Selection of the Best Drug Therapy
by James T. Kennedy, Jr, RPh, MBA
Read More
Original Research
Thromboembolic Events Associated with Bevacizumab plus Chemotherapy for Patients with Colorectal Cancer: A Meta-Analysis of Randomized Controlled Trials
Abdullah K. Alahmari, BPharm, PhD candidate, Ziyad S. Almalki, BPharm, PhD candidate, Ahmed K. Alahmari,, Medical Student, Jeff J. Guo, BPharm, PhD
Stakeholder Perspective
Better Patient Education Needed Regarding Thromboembolic Events Risk in Patients with Cancer
by Jeffrey A. Bourret, PharmD
Read More
FDA Approvals
Innovation Tops Current Trends in the 2016 Oncology Drug Pipeline
Dalia Buffery, MA, ABD
Read More
FDA Approvals, In the News
FDA Approves First Blood Test to Detect Gene Mutation Associated with Non–Small-Cell Lung Cancer
Read More
Page 110 of 244
Results 1091 - 1100 of 2438